SALT score

Advertisement

cGxPJobs Banner

Rezpegaldesleukin Shows Strong Phase 2b Results in AD

San Francisco, USA | March 28, 2026 Phase 2b Data Demonstrates Strong Clinical Efficacy Nektar Therapeutics has announced compelling...

By cGxPwire Editor
March 30, 2026

Read More

Advertisement

cGxPJobs

Directory